Same Indication

Muromonab-Cd3 vs Pembrolizumab

Muromonab-Cd3 vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Muromonab-Cd3 and Pembrolizumab.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days.

Chemical Properties

Type: Muromonab-Cd3 β€” Unknown; Pembrolizumab β€” Antibody.